News

Findings could identify aggressive breast cancers that will respond to immunotherapy

The U.S. Food and Drug Administration recently approved a treatment that combines an immunotherapy drug and chemotherapy for triple negative breast cancer, but not all cases of this aggressive form of breast cancer responded in clinical studies. UNC Lineberger researchers discovered biological clues that could help identify which tumors might…...

Read more

Blocking a survival mechanism could tackle melanoma treatment resistance

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications. Researchers from the Babraham Institute, AstraZeneca and the Cancer Research UK Cambridge Centre have demonstrated an approach, used in parallel with existing…...

Read more

Liver Cancer: Where We Are Now

Liver cancer is the sixth most common cancer in the world and 4th most common in Asia. It is the second deadliest cancer around the globe, taking more than 746,000 lives in 2012. In Asia, it is also the second deadliest cancer taking 558,000 lives that year. The ratio of…...

Read more

Liver cancer deaths climb by around 50% in the last decade

Liver cancer death rates have increased by around 50% in the last decade and have tripled since records began, according to the latest calculations by Cancer Research UK. New mortality data shows that there were around 5,700 deaths from liver cancer in 2017 in the UK, which is the highest ever yearly…...

Read more

Joint Research Symposium

The Asian Fund for Cancer Research and the U.S.-based National Foundation for Cancer Research recently collaborated in an unprecedented manner, with both organizations gathering together. A first-of-its kind partnership, the Joint NFCR and AFCR Scientific Symposium on Cancer Research and Global Collaboration was held in the U.S. state of Maryland…...

Read more

Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer

Using a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about cancer architecture and could aid the delivery of treatment to the most challenging tumours, new research shows. Magnetic resonance elastography was able to visualise and measure how stiff and dense tumours are in mice.…...

Read more

USCACA & AFCR 2019 Scholar Awards

The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2019 Scholar Awards. The Awards will recognize two to three junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research. Candidacy is open to all Chinese researchers who were trained…...

Read more

Quest for new cancer treatment crosses milestone

A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decades long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. According to the study, thirteen of the first 15 prostate cancer…...

Read more

Tasmanian devil research could help tackle immunotherapy resistance

A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system. This early work in cells could one day guide us towards new drug combinations that improve the effectiveness of immunotherapy treatments. Researchers at…...

Read more

Scientists evaluate cancer risk of US drinking water

Researchers from the Environmental Working Group (EWG) in Washington, DC, used a new approach to analyze cumulative cancer risk due to carcinogens in tap water across the U.S. This study is the first to apply a “cumulative cancer risk framework” to the analysis of tap water contaminants for the whole of the U.S.…...

Read more